The Peptide List
Publishes 1 feed
The Peptide List
Independent peptide intelligence: clinical evidence, provider and lab scrutiny, regulatory shifts, and the genetics research behind why response varies.
10 posts · theirs
Lately
The Human Proteome Was Never Finished
Scientists Built a Peptide That Tags Alzheimer’s Amyloid for Destruction
The Immune System Learned to Attack Gluten. Scientists Are Trying to Teach It to Stop.
Nobody Built an Exit From Ozempic
Enclomiphene Lost Every Vote It Ever Faced. That Is Why You Can Buy It.
Nobody Was Asking Anymore. The FDA Voted Anyway.
SS-31 Was an Anti-Aging Peptide. Now It’s a Barth-Syndrome Drug.
GLP-1s Are Organ Drugs Now. Weight Loss Is the Side Effect.
Why Mounjaro Makes You Vomit and Ozempic Doesn’t. It’s Your GIPR Gene.
The FDA’s Own Scientists Said No. The Panel That Decides Sells Peptides.
Everything on this page was read from markup The Peptide List published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON